Transfer pricing is not synonymous with tax avoidance, Stemcor said in response to ‘allegations’
Examining the key tax issues facing this sector. By Eloise Walker, Heather Self, John Christian, and Alison Walker (Pinsent Masons), with in-house views from Robert Fort Ferrovial) on tax competitiveness and David Murphy (Bechtel) on risk management issues for international EPC contracting.
Dominic Stuttaford and Andrew Roycroft (Norton Rose) examine developments in tax affecting the attractiveness of the UK as a location for insurance group holdings, the VAT exemption for intermediaries rules, VAT on insurance restructurings and the increasing importance of insurance premium tax. Jennie Rimmer (Aspen) provides (below) an in-house perspective.
Martin Zetter reports on a recent OECD working party meeting
The first of a new series of ‘sector focus’ reports examines the tax challenges facing pharmaceutical companies. By Chris Sterling, Andrew Hickman, Jonathan Bridges and Komal Dhall of KPMG, with in-house perspectives from Tim Woodthorpe and Helen Jones of GSK and Koichi Funabashi of Astellas.
The public is losing trust in ‘a system that is in need of drastic reform’, says The Taxpayers’ Alliance
Comments on three discussion drafts are published
KPMG welcomes progress on advance pricing agreements
There is a risk that revised controlled foreign companies rules will encourage transfer of profits into tax havens, says International Development Committee
Information is presented 'in a more logical way'